| Term Name: | 3-[beta-D-Glc-(1->6)-beta-D-Glc-(1->6)-beta-D-Glc-yl]-1,2-dimyristoyl-sn-glycerol |
|---|---|
| Synonyms: | (2S)-3-{[beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranosyl]oxy}propane-1,2-diyl ditetradecanoate, (2S)-3-{[beta-D-glucosyl-(1->6)-beta-D-glucosyl-(1->6)-beta-D-glucosyl]oxy}propane-1,2-diyl dimyristoylate, 3-[beta-D-Glcp-(1->6)-beta-D-Glcp-(1->6)-beta-D-Glcp-yl]-1,2-dimyristoyl-sn-glycerol, WH103 |
| Definition: | A glycosylglycerol derivative in which the glycosyl moiety of glycosyl-sn-glycerol is β-D-glucosyl-(1→6)-β-D-glucosyl-(1→6)-β-D-glucosyl attached at O-3, with O-1 and O-2 both carrying myristoyl substituents. Synthetic C. difficile lipoteichoic acid (LTA) molecule consisting only of lipid + core region. |
| Ontology: | ChEBI [CHEBI:149784] ( EBI ) |